Skip to content
healthcare.dev
Get a free key

Shingrix

NDC 58160-849, Zoster Vaccine Recombinant, Adjuvanted, injection, solution, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-849
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125614
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-849 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN50 ug/.5mL
Package NDCNDC-11Package
58160-849-525816008495210 SYRINGE in 1 CARTON (58160-849-52) / .5 mL in 1 SYRINGE (58160-849-43)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58160-849 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-849 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-849. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.